论文部分内容阅读
Ｃ－ｅｒＢ－２基因蛋白在人乳腺癌中的过渡表达已被人们重视。它是细胞繁殖、增殖的一种指标，与肿瘤细胞恶性程度，临床预后及转移有相关性。本文用ＡＢＣ法，检测１５例乳癌，其中８例阳性，占５３％，良性１５例中，仅２例阳性，占１３％。经统计学Ｘ￣２检验有差异性，通过Ｃ－ｅｒＢ－２检测可帮助良恶性组织的鉴别，为临床综合性治疗提供依据。同进测定乳腺组织的ＥＲ和ＰｇＲ可与Ｃ－ｅｒＢ－２同为临床指导术后治疗。
The overexpression of C-erB-2 gene protein in human breast cancer has been valued by people. It is an indicator of cell proliferation and proliferation, and has a correlation with the degree of malignancy, clinical prognosis and metastasis of tumor cells. This article used ABC method to detect 15 cases of breast cancer, of which 8 cases were positive, accounting for 53%, benign in 15 cases, only 2 cases were positive, accounting for 13%. The statistical X ̄ 2 test is different, through the C-erB-2 test can help identify the benign and malignant tissue, provide a basis for clinical comprehensive treatment. Simultaneous determination of ER and PgR in mammary gland tissue and C-erB-2 can be clinically guided postoperative treatment.